SLC16A3 and colonic neoplasm: However, the expression levels of PDLIM3 and SLC16A3 are not significantly altered in colon tumor stroma (p < 0.05) and the expression level of FBN2 showed the opposite trend in the high-CAFs group (Figure 9C).